O.S.C.A.R. (OPERATING SYSTEM FOR CONTROL AND RECORD KEEPING)

K092991 · Environmental Tectonics Corp. · CBF · Aug 13, 2010 · Anesthesiology

Device Facts

• Record ID: K092991
• Device Name: O.S.C.A.R. (OPERATING SYSTEM FOR CONTROL AND RECORD KEEPING)
• Applicant: Environmental Tectonics Corp.
• Product Code: CBF · Anesthesiology
• Decision Date: Aug 13, 2010
• Decision: SESE
• Submission Type: Traditional
• Regulation: 21 CFR 868.5470
• Device Class: Class 2
• Attributes: Therapeutic, 3rd-Party Reviewed

Intended Use

The O.S.C.A.R. system is intended for use as an ancillary device for the support of whole-body oxygen administration to a patient at greater than ambient atmospheric pressure (hyperbaric oxygen) as prescribed by a physician. It is a device intended to provide control of Pressure Vessels for Human Occupancy without change to their established indications for use. The specific manufacturer's devices intended for use are Environmental Tectonics Corp.'s BARAMED 30" and XD monoplace models.

Device Story

O.S.C.A.R. (Oxygen System Control and Regulation) functions as an ancillary control system for Environmental Tectonics Corp. BARAMED 30" and XD monoplace hyperbaric chambers. Device provides automated control of pressure vessels for human occupancy during hyperbaric oxygen therapy. Operated by trained clinical staff in a hospital or clinical setting under physician supervision. System manages pressure regulation to support whole-body oxygen administration. Output allows clinicians to maintain precise hyperbaric environments for patients with specific medical conditions. Benefits include standardized control of chamber pressure, ensuring consistent delivery of prescribed hyperbaric oxygen therapy.

Clinical Evidence

No clinical data provided; device is an ancillary control system for previously cleared hyperbaric chambers.

Technological Characteristics

Ancillary control system for monoplace hyperbaric chambers. Interfaces with BARAMED 30" and XD models to regulate pressure. Operates as a control interface for pressure vessels for human occupancy. No specific materials, energy sources, or software architecture details provided in the summary.

Indications for Use

Indicated for patients requiring hyperbaric oxygen therapy for 13 conditions: air/gas embolism, carbon monoxide poisoning (with/without cyanide poisoning), clostridial myositis/myonecrosis, crush injury/compartment syndrome/acute traumatic ischemias, decompression sickness, problem wound healing, exceptional blood loss (anemia), intracranial abscess, necrotizing soft tissue infections, refractory osteomyelitis, delayed radiation injury, compromised skin grafts/flaps, and thermal burns. Prescription use only under physician supervision.

Regulatory Classification

Identification

A hyperbaric chamber is a device that is intended to increase the environmental oxygen pressure to promote the movement of oxygen from the environment to a patient's tissue by means of pressurization that is greater than atmospheric pressure. This device does not include topical oxygen chambers for extremities (§ 878.5650).

Reference Devices

• BARAMED 30" (Environmental Tectonics Corp.)
• XD monoplace models (Environmental Tectonics Corp.)

Submission Summary (Full Text)

{0}------------------------------------------------

## DEPARTMENT OF HEALTH & HUMAN SERVICES

Image /page/0/Picture/1 description: The image contains the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized graphic of a human figure, with three arms or lines extending upwards, and the text "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" arranged in a circular fashion around the graphic. The graphic and text are in black and white.

Public Health Service

Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002

Environmental Tectonics, Corporation C/O Mr. Daniel W. Lehtonen Responsible Third Party Official Intertek Testing Services 2307 East Aurora Road, Unit B7 Twinsburg, Ohio 44087

Re: K092991

Trade/Device Name: O.S.C.A.R. Regulation Number: 21 CFR 868.5470 Regulation Name: Hyperbaric Chamber Regulatory Class: II Product Code: CBF Dated: August 5. 2010 Received: August 6, 2010

Dear Mr. Lehtonen:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations. Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

AUG 1 3 2010

{1}------------------------------------------------

## Page 2- Mr. Lehtonen

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to

http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers. International and Consumer Assistance at its toll-free number [phone] or [phone] or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely vours.

Nh for

Anthony D. Watson, B.S., M.S., M.B.A. Director

Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health

## Enclosure

{2}------------------------------------------------

## Indications for Use

K 092991

AUG 1 3 2010

510(k) Number: K092991 Device Name: O.S.C.A.R. Indications For Use:

Indications for Use:

The O.S.C.A.R. system is intended for use as an ancillary device for the support of whole-body oxygen administration to a patient at greater than ambient atmospheric pressure (hyperbaric oxygen) as prescribed by a physician. It is a device intended to provide control of Pressure Vessels for Human Occupancy without change to their established indications for use. The specific manufacturer's devices intended for use are Environmental Tectonics Corp.'s BARAMED 30" and XD monoplace models.

The FDA has cleared the use of hyperbaric chambers under 13 specific medical conditions that are based on the Undersea and Hyperbaric Medicine Society (UHMS)'s indications. These are:

- Air or Gas Embolism .
- Carbon Monoxide Poisoning and Carbon Monoxide Poisoning complicated by Cyanide Poisoning
- Clostridial Myositis and Myonecrosis (Gas Gangrene)
- Crush Injury, Compartment Syndrome and other Acute Traumatic Ischemias
- Decompression Sickness
- Enhancement of Healing in Selected Problem Wounds
- Exceptional Blood Loss (Anemia)
- Intracranial Abscess
- Necrotizing Soft Tissue Infections
- Osteomvelitis (Refractory)
- Delayed Radiation Injury (Soft Tissue and Bony Necrosis)
- Skin Grafts and Flaps (Compromised)
- Thermal Burns

It is a prescription device that is intended for sale and use by or on the order and under the medical supervision of a physician.

× AND/OR Prescription Use (Part 21 CFR 801 Subpart D)

Over-The-Counter Use (21 CFR 801 Subpart C)

Page 1 of

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IFNEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

Jivision Sign-Off) vision of Anesthesiology, General Hospital ntection Control, Dental Devices

510(k) Number: K092991